Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
null nullEdward Pk ParkerJohn TazareWilliam J HulmeChristopher BatesEdward J CarrJonathan CockburnHelen J CurtisLouis FisherAmelia Ca GreenSam HarperFrank HesterElsie Mf HorneFiona LoudSusan LyonViyaasan MahalingasivamAmir MehrkarLinda NabJohn ParryShalini SanthakumaranRetha SteenkampJonathan A C SterneAlex J WalkerElizabeth J WilliamsonMichelle WillicombeBang ZhengAlex J WalkerDorothea NitschLaurie A TomlinsonPublished in: BMJ open (2023)
Although high primary vaccine and booster dose coverage has been achieved among people with kidney disease in England, key disparities in vaccine uptake remain across clinical and demographic groups and 4-dose coverage is suboptimal. Targeted interventions are needed to identify barriers to vaccine uptake among under-vaccinated subgroups identified in the present study.